Findings from four pooled studies of brain biopsies showed the experimental PET imaging agent F-18 flutemetamol to have 93% sensitivity and 100% specificity in detecting beta amyloid plaque, which has been linked to Alzheimer's disease. Results of a brain autopsy study showed the agent diagnosed amyloid with an 86% sensitivity and 92% specificity.

Related Summaries